Skip to content
2000
Volume 3, Issue 3
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Chronic lung disease in the extremely preterm baby is still a major complication in neonatal intensive care. Perinatal (ante- and neonatal) glucocorticoids are widely used to prevent severe infant respiratory distress syndrome and/or to reduce chronic lung disease respectively. A review of the literature regarding the cardiovascular side effects of antenatal and neonatal glucocorticoids is presented here.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/157339607781369564
2007-08-01
2025-09-05
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/157339607781369564
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test